U.S. Industrial REITs Stock News

Crinetics Pharmaceuticals has delivered a very strong share price run over the past three years, yet its current valuation screens as expensive on market multiples and the broader checks only give it a mixed score. That combination leaves investors weighing a powerful recent return against signals that the stock is not clearly cheap at today’s price of US$84.75. Crinetics Pharmaceuticals has returned 428.0% over the past three years, which sets a high bar for any further gains to be...

Karman Holdings earnings, guidance and financing moves in focus Karman Holdings (KRMN) is in focus after second quarter 2026 results, updated full year revenue guidance and a refinancing of its credit facilities that changes the cost of its existing debt structure. See our latest analysis for Karman Holdings. Karman Holdings' latest earnings, raised revenue guidance and credit agreement amendment come after a period where the share price has been volatile. The stock has a 1 month share price...

NextDecade (NEXT) has drawn investor attention after recent share price moves, with the stock closing at $6.95 on 18 August 2026. The company focuses on US liquefied natural gas export and carbon capture projects. See our latest analysis for NextDecade. Against that backdrop, NextDecade’s share price has pulled back in the short term, with a 30 day share price return down 9.51% and a 90 day share price return down 22.52%, while the year to date share price return of 29.18% contrasts with a 1...

Newmark Group, Inc. announced that long-serving CEO Barry Gosin, in the role since 1979, will step down on December 31, 2026, while remaining Chairman of Newmark & Company Real Estate, Inc. to support a smooth leadership transition. This leadership change comes as Newmark shows resilience in commercial real estate, with growing management services, leasing, and capital markets businesses despite broader sector challenges. Next, we’ll examine how Gosin’s planned CEO handover could influence...

Qualys stock has delivered a 67.1% total return over the past five years, and today an intrinsic value estimate based on a Discounted Cash Flow, or DCF, approach points to upside while market multiples lean the other way. That split, combined with a mixed value score, raises questions about how much of the story is already reflected in the current US$183.31 share price. Over five years, Qualys has returned 67.1%, which suggests the market has already rewarded the company for a meaningful...

Atlassian (NasdaqGS:TEAM) is back in focus after reporting fourth quarter earnings that moved from a prior year net loss to net income, alongside record backlog growth and stronger enterprise customer adoption. See our latest analysis for Atlassian. Atlassian's recent earnings, new AI driven Code Context feature, leadership changes, and a fresh shelf registration have played out against a sharp shift in sentiment, with a 30 day share price return of 69.73% and a 90 day return of 82.8%, even...

Monarch Casino & Resort (MCRI) reported Q2 results with revenue up 4.2% year over year, record second quarter profitability, and near record adjusted EBITDA margins, yet the stock slipped 1.7% after the release. See our latest analysis for Monarch Casino & Resort. At a share price of $123.65, Monarch Casino & Resort has a year to date share price return of 28.75%, while the 1 year total shareholder return of 23.89% and 3 year total shareholder return of 96.18% point to momentum that has...

In early August 2026, Remitly Global, Inc. reported strong second-quarter 2026 results, with sales rising to US$495.16 million and net income reaching US$205.91 million, alongside higher earnings per share versus a year earlier. The company also lifted its 2026 revenue outlook to about US$1.98 billion and guided for further net income growth, prompting an analyst rating upgrade and sizeable upward revisions to earnings estimates. We’ll now examine how Remitly’s raised full-year guidance and...

Over the last 7 days, the United States market has remained flat, yet it is up 19% over the past year with earnings expected to grow by 17% annually in the coming years. In this context, identifying stocks that are potentially undervalued and exhibit insider action can be a strategic approach for investors looking to capitalize on opportunities within small-cap companies.

In the last week, the market has stayed flat, yet over the past 12 months, it has risen by 19%, with earnings expected to grow by 17% per annum in the coming years. In this context of robust growth and stability, identifying high-growth tech stocks that align well with these positive market conditions can be crucial for investors seeking potential opportunities in August 2026.

In the last week, the United States market has remained flat, yet it has experienced a 19% increase over the past year with earnings projected to grow by 17% annually. In this context, identifying stocks that are trading below their intrinsic value can be advantageous for investors seeking opportunities within a robust market environment.

The United States market has shown a steady trajectory, remaining flat over the last week but up 19% over the past year, with earnings forecast to grow by 17% annually. In such an environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those who know the business best.

In the last week, the market has stayed flat, but it is up 19% over the past year with earnings expected to grow by 17% per annum over the next few years. Though often considered a relic of past trading days, penny stocks still offer opportunities for those interested in smaller or newer companies that can lead to significant returns when built on solid financials. This article highlights three examples of penny stocks that combine balance sheet strength with potential for outsized gains,...

In the last week, the United States market has stayed flat, but it has seen a 19% increase over the past year with earnings forecasted to grow by 17% annually. In this environment, dividend stocks with attractive yields can offer investors a steady income stream while potentially benefiting from overall market growth.

Talk of 50% US tariffs on around $20.2b of Canadian exports has turned a usually quiet corner of the market into a live story about cross border consumer demand, supply chains and brand loyalty. For investors, that kind of policy risk can create both mispricing and fresh opportunity. This article walks through three US consumer stocks exposed to this news and why each could matter for your portfolio. The three stocks covered below are a starting sample, and the wider screen surfaced 18 more...

Earlier this month, Quanta Services reported a strong Q2 with its backlog rising about 50% year over year to US$53.40 billion, reflecting robust demand for AI-related energy infrastructure, electrification, and grid expansion projects. The company’s expanding backlog and upward earnings revisions, including expectations to more than double adjusted EPS by 2030, highlight how investors are focusing on Quanta’s role as a core contractor for the AI-driven power buildout and broader energy...

Hut 8 stock has delivered a 260.5% gain over the past year, yet its valuation checks still lean expensive, which raises questions about how much of the AI data center story is already reflected in the price. Over the last 12 months, Hut 8 is up 260.5%. This suggests very high expectations are already baked into the share price. The build out of Hut 8's AI focused data center pipeline and large contracted revenue backlog can support long term cash flows. At the same time, regulatory reviews...

Sempra (SRE) stock is reacting to fresh numbers after the company reported second quarter 2026 results, with higher net income and earnings per share, and adjusted its 2026 outlook while reaffirming 2027 guidance. See our latest analysis for Sempra. At a share price of US$85.94, Sempra has seen its short term share price performance soften, with a 30 day share price return down 6.84%. However, longer term total shareholder returns of 9.18% over one year and 52.43% over five years point to a...

ResMed stock has delivered a 36.4% gain over the past three years, yet the current share price still screens as cheap relative to an intrinsic value estimate from a Discounted Cash Flow (DCF) model and to market based multiples. Over the last three years ResMed has returned 36.4%, which puts recent weakness into context for anyone focused on longer holding periods. The latest pullback followed softer longer term revenue expectations linked to suspended ventilator sales and cost pressures...

Burlington Stores (BURL) is back in focus after announcing a planned change in its top human resources role, raising fresh questions about leadership continuity, culture and long term execution for the off price retailer. See our latest analysis for Burlington Stores. The leadership reshuffle comes after a mixed stretch for Burlington Stores, with the share price down 9.33% over the past week and 2.45% over the past month, yet still showing a 17.74% 90 day share price return and a 21.30% one...

Arrowhead Pharmaceuticals has already obtained European marketing authorisation for REDEMPLO (plozasiran) to help reduce triglyceride levels in adults with familial chylomicronaemia syndrome, based on positive Phase 3 PALISADE data showing significant median fasting triglyceride reductions versus placebo at the 25 mg dose. This approval marks Arrowhead’s transition from a pure development-stage RNAi player toward commercialisation in a rare disease with high unmet medical need and serious...

In August 2026, Genpact reported second-quarter 2026 results showing year-over-year growth in sales to US$1,343.44 million and higher net income of US$145.74 million, alongside updated guidance calling for continued revenue and earnings expansion through the third quarter and full year. At the same time, Genpact was named to TIME magazine's World's Most Sustainable Companies 2026 list for the second consecutive year, underlining how its financial performance is increasingly paired with...

Why Zacks Coverage Has Put Fresh Attention on VEON Recent Zacks coverage spotlighted VEON (VEON) for what it described as favorable valuation metrics and a strong earnings outlook. This recognition appears to be a key reason the stock is drawing more investor attention. See our latest analysis for VEON. Over the past month VEON has seen an 11.35% share price return to US$57.48, while its year to date share price return of 9.07% contrasts with a 1 year total shareholder return that is down...

Photronics has delivered a 151.9% total return over the past five years, yet its valuation checks send a mixed message at a time when the stock is under scrutiny following securities fraud class action filings in 2026. A 151.9% return over five years suggests Photronics has rewarded long term shareholders, which raises the question of how much of that success is already reflected in today's price. On one side, growth expectations for high end chip related demand can support interest in the...